Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Burning Rock Biotech (BNR) Revenue: 2020-2024

Historic Revenue for Burning Rock Biotech (BNR) over the last 5 years, with Dec 2024 value amounting to $70.7 million.

  • Burning Rock Biotech's Revenue fell 4.46% to $18.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.2 million, marking a year-over-year decrease of 1.36%. This contributed to the annual value of $70.7 million for FY2024, which is 6.64% down from last year.
  • Latest data reveals that Burning Rock Biotech reported Revenue of $70.7 million as of FY2024, which was down 6.64% from $75.7 million recorded in FY2023.
  • Burning Rock Biotech's Revenue's 5-year high stood at $81.7 million during FY2022, with a 5-year trough of $65.9 million in FY2020.
  • Moreover, its 3-year median value for Revenue was $75.7 million (2023), whereas its average is $76.0 million.
  • In the last 5 years, Burning Rock Biotech's Revenue rose by 20.96% in 2021 and then fell by 7.31% in 2023.
  • Burning Rock Biotech's Revenue (MRY) stood at $65.9 million in 2020, then rose by 20.96% to $79.7 million in 2021, then increased by 2.47% to $81.7 million in 2022, then decreased by 7.31% to $75.7 million in 2023, then fell by 6.64% to $70.7 million in 2024.
  • Its Revenue was $70.7 million in FY2024, compared to $75.7 million in FY2023 and $81.7 million in FY2022.